Motawea Karam R, Monib Fatma A, Shaheen Nour
Alexandria, Egypt Faculty of Medicine, Alexandria University.
Assiut, Egypt Faculty of Medicine, Assiut University.
Indian J Otolaryngol Head Neck Surg. 2023 Apr 20;75(3):1-5. doi: 10.1007/s12070-023-03745-x.
COVID-19 has infected millions of people worldwide causing millions of deaths. COVID-19 has many serious effects on organs of the body especially the respiratory system causing pneumonia and acute respiratory distress syndrome (ARDS). The disease also has severe complications on other different organs; kidneys and liver which may end in multi-organ failure. Most common symptoms that have been detected in large section of patients were fever, cough and loss of taste or smell and less commonly sore throat, headache and muscle pain. The incidence of vertigo or dizziness is a rare symptom of COVID-19. In this case report, we introduce a 59-year-old male patient suffering from acute vertigo attack after COVID-19 infection. The patient had negative medical history of vertigo and any ear diseases. The patient received REGEN-COV (casirivimab and imdevimab) for COVID-19 and meclizine for vertigo. Vertigo attacks lasted for the two weeks follow up after disappearance of COVID-19 symptoms despite receiving vertigo medication. In conclusion, vertigo may be the sole neurological manifestation of COVID-19. More observational studies should address this symptom and researchers should also focus on identifying the origin of developing vertigo and the direct or indirect mechanisms that SARS-CoV-2 triggers to develop dizziness in general. This research should deliver a clear message, especially to ER physicians to consider proper referral of these patients without underestimating the risk of developing more serious COVID-19 symptoms as ARDS and multi-organ failure if no proper testing and follow-up are provided.
新冠病毒已在全球感染数百万人,导致数百万人死亡。新冠病毒对人体器官有许多严重影响,尤其是呼吸系统,会引发肺炎和急性呼吸窘迫综合征(ARDS)。该疾病对其他不同器官也有严重并发症,如肾脏和肝脏,可能导致多器官功能衰竭。在大部分患者中检测到的最常见症状是发热、咳嗽和味觉或嗅觉丧失,较少见的症状有喉咙痛、头痛和肌肉疼痛。眩晕或头晕的发生率是新冠病毒的一种罕见症状。在本病例报告中,我们介绍了一名59岁男性患者,在感染新冠病毒后出现急性眩晕发作。该患者既往无眩晕病史及任何耳部疾病。该患者接受了用于治疗新冠病毒的REGEN-COV(卡西瑞维单抗和依德维单抗)以及用于治疗眩晕的美克洛嗪。尽管服用了眩晕药物,但在新冠病毒症状消失后的两周随访期间,眩晕发作仍持续。总之,眩晕可能是新冠病毒唯一的神经学表现。更多的观察性研究应关注这一症状,研究人员还应专注于确定眩晕发生的根源以及新冠病毒引发头晕的直接或间接机制。这项研究应传达一个明确的信息,尤其是给急诊科医生,要考虑对这些患者进行适当转诊,而不要低估如果不进行适当检测和随访而出现更严重的新冠病毒症状如ARDS和多器官功能衰竭的风险。